Cassava Technologies is on a mission and it’s not even subtle. If you weren’t paying attention, it’s all about boosting and then dominating an African AI ecosystem. The company has a deal ...

CONTAIN CONCERNING LEVELS OF LEAD. WHETHER YOU’RE REACHING FOR CRUNCHY SNACKS OR GLUTEN FREE COMFORT FOODS, CASSAVA IS SHOWING UP IN MORE PRODUCTS THAN EVER. BUT BEHIND THE HEALTH HALO LIES A ...

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is ...

Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...

(n.) A shrubby euphorbiaceous plant of the genus Manihot, with fleshy rootstocks yielding an edible starch; -- called also manioc. (n.) A nutritious starch obtained from the rootstocks of the cassava ...

BATON ROUGE, La. (CONSUMER REPORTS) - Cassava, also known as yuca or manioc, was once known mostly in Caribbean, African, and South American cuisines—but has grown in popularity, popping up as ...

Cassava Technologies has partnered with Vambo AI, an African start-up, to accelerate the development and rolling out of AI solutions that address the continent's unique linguistic, cultural, and ...

The saga of Cassava Sciences' development of Alzheimer's disease therapy simufilam has come to its dismal end. The company has reported top-line data from a second phase 3 trial of the drug ...